We believe Allianze now has more value to AeonCR. We also take chance to sell some MBsB

We have acquired and sold Success before. The current price of Success and its just released result has triggered us to re-look into the company. We believe the current price level is good but waiting for a bargain when it below RM 0.900. It will be around PE 4 times plus 40% traded below its NTAB.

We still favour Ahealth as a long term holding company not just in its industry but its records of profitability and growth strategy in the pass few years. Below RM 2.80 trigger our purchase interest and we added some at RM 2.780

The last two weeks strange volume increase and price upward trend signalling either funds are buying up this counter or there is a corporate exercise mulling. Although we have not acquired up to our target holding, we are please that someone share our view positively together.

As bargain hunting first steps started, we have bought a few counters. We will buy more gradually.

We bought Tomei today at RM 0.800 and Stemlfe RM 0.305

Renew Europe crisis, Malaysia general election is about to come, JP Morgan trading losses, China weak data, yet, most market still hold well with mild down trend. To me it is a little strange and the only conclusion is money getting smaller. The market still trend up in mid – term because everything is going to be more expensive. Inclusive stocks

As part of our consolidation process of our portfolio, we have sold Silverlake and switched to Ascott REIT. We will continue to do so and embrace the strategy of focus holding of quality company in the coming months. Mean time, we still in defensive mode with cautiously optimistic

Luxchem at RM 1.180 and FocusP at RM 0.300